Smart-4-Fabry is the acronym of a H2020 funded Project
that stands for “Smart functional GLA-nanoformulation
for Fabry disease”. Smart-4-Fabry is a collaborative project
funded under the H2020 EU Research
and Innovation programme.
The project started on
the 1st January 2017 and will last four years.
Researchers and clinicians working in the field of lysosomal disorders had the opportunity...
Genetic deficiencies of lysosomal components, most commonly enzymes, are known as “l...
The CLINAM Summit is a globally unique event that brings together all stakeholders in nano...